Laparoscopic right hemicolectomy for metastatic renal cell carcinoma in the ascending colon: A case report.
Colonic metastasis
Laparoscopic right hemicolectomy
Renal cell carcinoma
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
2020
2020
Historique:
received:
05
08
2020
revised:
26
08
2020
accepted:
26
08
2020
pubmed:
7
9
2020
medline:
7
9
2020
entrez:
6
9
2020
Statut:
ppublish
Résumé
Renal cell carcinoma (RCC) arises from the renal parenchyma and is the most common primary malignancy of the kidney. RCC frequently metastasizes to the lung, bone, lymph nodes, and other locations, but rarely to the colon. We report a case of metastatic RCC of the ascending colon that was successfully resected with laparoscopic right hemicolectomy. The patient is a 65-year-old man who developed hip joint pain and was diagnosed with polymyalgia rheumatica during the first year after laparoscopic right nephrectomy for right RCC. A screening colonoscopy was performed and a tumor was found in the ascending colon. Biopsy strongly suggested metastatic RCC. No other distant metastases were found, and laparoscopic right hemicolectomy was performed. The tumor extended from the mucosa to the subserosa and was diagnosed histopathologically as colonic metastasis of RCC. There were no lymph node metastases in the simultaneously resected mesentery, but venous invasion was observed. RCC can metastasize to various organs, but metastasis to the colon is extremely rare. In cases of colon metastasis, abdominal symptoms, hematochezia, or anemia may occur, and their occurrence should be checked during follow-up. Based on past reports, resection of metastatic lesion is considered the most appropriate treatment. Although it is rare for RCC to metastasize to the colon, it is possible. Resection can be recommended for colon metastasis with no other metastases, and colectomy with R0, including the regional mesocolon, may provide a favorable long-term prognosis.
Identifiants
pubmed: 32892122
pii: S2210-2612(20)30650-7
doi: 10.1016/j.ijscr.2020.08.050
pmc: PMC7481497
pii:
doi:
Types de publication
Case Reports
Langues
eng
Pagination
214-217Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Int J Urol. 1996 Nov;3(6):501-3
pubmed: 9170582
Lancet. 2009 Mar 28;373(9669):1119-32
pubmed: 19269025
Int J Surg Case Rep. 2016;27:55-58
pubmed: 27543725
Int J Urol. 2002 Jan;9(1):19-23
pubmed: 11972645
Curr Treat Options Oncol. 2003 Oct;4(5):363-72
pubmed: 12941196
J Clin Oncol. 2014 Dec 20;32(36):4059-65
pubmed: 25403213
Asian J Urol. 2019 Apr;6(2):210-214
pubmed: 31061809
Acta Chir Belg. 2008 Mar-Apr;108(2):264-5
pubmed: 18557158
World J Surg Oncol. 2010 Jun 29;8:54
pubmed: 20587023
Ann Oncol. 2012 Apr;23(4):973-80
pubmed: 21890909
Vojnosanit Pregl. 2013 Sep;70(9):881-6
pubmed: 24266320
Int J Surg. 2018 Dec;60:132-136
pubmed: 30342279
Int J Surg Case Rep. 2019;65:152-155
pubmed: 31707304
BJU Int. 2013 Nov;112(7):909-16
pubmed: 23890378
Lancet Oncol. 2014 Nov;15(12):e549-61
pubmed: 25439697
Eur J Surg Oncol. 1998 Apr;24(2):149-51
pubmed: 9591035